Anzeige
Mehr »
Login
Samstag, 08.08.2020 Börsentäglich über 12.000 News von 643 internationalen Medien
NEU! Unglaublich, aber wahr! Bis zu 1.000% mit dieser Gold-Kupfer-Aktie! Das ist Ihr nächstes Millionen-Los!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 896047 ISIN: US09058V1035 Ticker-Symbol: BO1 
Tradegate
07.08.20
21:44 Uhr
3,402 Euro
+0,033
+0,98 %
1-Jahres-Chart
BIOCRYST PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
BIOCRYST PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,3303,39912:34
3,3333,39407.08.

Aktuelle News zur BIOCRYST PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBioCryst Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation18
DoHotStocks USA: AMERICAN AIRLINES und BIOCRYST stark gehandelt25
BIOCRYST PHARMACEUTICALS Aktie jetzt für 0€ handeln
MoIs BioCryst Pharmaceuticals Stock a Buy?38
MoBioCryst Pharma's BCX9930 Fast Track'd for red blood cell disease13
MoBIOCRYST PHARMACEUTICALS INC - 8-K, Current Report11
23.07.BioCryst Pharmaceuticals, Inc.: BioCryst to Report Second Quarter 2020 Financial Results on August 654
20.07.BioCryst Pharmaceuticals: Important Catalysts Could Drive Additional Upside In 2H 202052
15.07.Better Buy: Moderna vs. BioCryst Pharmaceuticals74
08.07.Pre-market Movers In Healthcare Sector: NNVC, BCRX, XENT, VVUS…30
07.07.BioCryst Pharmaceuticals Jumped Higher Today; Here's Why Investors May Be Wrong74
02.07.BioCryst Pharmaceuticals, Inc.: BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)40
26.06.Why BioCryst Pharmaceuticals Stock Jumped Today69
11.06.BioCryst Berotralstat PDUFA, And Other News: The Good, Bad And Ugly Of Biopharma47
10.06.BIOCRYST PHARMACEUTICALS INC - S-8, Securities to be offered to employees in employee benefit plans16
09.06.BRIEF-Biocryst Announces Berotralstat Expanded Access Program For Patients With Hereditary Angioedema In United States9
09.06.BioCryst Pharmaceuticals, Inc.: BioCryst Announces Berotralstat Expanded Access Program for Patients with Hereditary Angioedema in United States8
08.06.Here's Why BioCryst Pharmaceuticals Jumped 15% in May14
08.06.BioCryst's berotralstat long term study suggests reductions in attack rate13
06.06.BioCryst Pharmaceuticals, Inc.: Hereditary Angioedema Patients Report Breakthrough Attacks on Current Injectable/Infused Prophylaxis Medication18
06.06.BioCryst Pharmaceuticals, Inc.: Long-term (48-week) Data Show Treatment with Berotralstat Provides Robust and Durable Reductions in HAE Attacks and Improvements ...20
Seite:  Weiter >>
92 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,25